Press Release | February 9, 2026
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
Read More
Press Release | January 23, 2026
Alveus Therapeutics Announces FDA Clearance of IND and First Patient Dosed in Phase 1b Trial of ALV-100 for Obesity
Read More
Press Release | January 21, 2026
Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal
Read More
News | January 15, 2026
JPM26: As Capital Concentrates, VCs Scrutinize Founder Pedigree and CEO Fit in Early Biotech
Read More
